Search clinical trials for: PEG-IFNa 2a

Total 7762 results

National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

Hepatitis B, Chronic

Taiwan
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...

Completed

SR-BI and Antiviral Treatment Response in HCV

Chronic Hepatitis C
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Hepatitis B, Chronic

New Zealand
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy

Bowel Preparation for Colonoscopy

Mexico
Charles University, Czech Republic

Not yet recruiting

Variability of Healthy People and People After Stroke Results in the Nine Hole Peg Test

Motor Activity

Czechia
Zhongnan Hospital

Not yet recruiting

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Granulocyte Colony-Stimulating Factor

China
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma
Xiaohua Wu MD

Not yet recruiting

Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies

Gynecologic Malignant Tumor

China
Evergreen General Hospital, Taiwan

Completed

Renal Safety of Bowel Preparation With Polyethylene Glycol

Acute Kidney Injury

Taiwan
Boehringer Ingelheim

Completed

A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers

Healthy
Savient Pharmaceuticals

Completed

Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout

Gout

United States, Canada, Mexico
Parkview Health

Withdrawn

Comparison Study in Pancreatic Fiducial Placement

Pancreatic Neoplasms

United States
Sichuan University
Afﬁliated Hospital of North Sichuan Medical College; Affiliated Hospital of...

Completed

Effect of Lactulose and/or Polyethylene Glycol Solution for Bowel Preparation for Colonscopy Procedures

Colonoscopy

China
University of Turin, Italy

Unknown

Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

Chronic Hepatitis C

Italy
Joke Wuyts
Association of Belgian Pharmacies (APB)

Completed

Studying the Impact of a Medication Use Evaluation by the Community Pharmacist (SIMENON)

Aging
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)

Hepatitis B, Chronic

China
Changhai Hospital
The First Affiliated Hospital of Nanchang University; The Second Hospital of... and other collaborators

Completed

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

Bowel Preparation for Colonoscopy

China
PharmaEssentia

Completed

Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects

Healthy Volunteers

Canada
Hoffmann-La Roche

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Hepatitis B, Chronic

Taiwan
Gilead Sciences

Completed

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Hepatitis C, Chronic

United States, Puerto Rico, Australia
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Bioavailability Study of Two Different PEG-rhGH Preparations.

Pediatric Growth Hormone Deficiency (PGHD)

China
Huazhong University of Science and Technology
Peking Union Medical College

Completed

A Real-world Comparison of FNB and FNA in IHC-required Lesions.

Gastrointestinal Stromal Tumors | Neuroendocrine Tumors | Autoimmune Pancreatitis

China
Rigshospitalet, Denmark

Unknown

The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma

Melanoma

Denmark
Hoffmann-La Roche

Completed

A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Israel
Vertex Pharmaceuticals Incorporated
ViroChem Pharma

Completed

Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection

Hepatitis C

Canada, United States, Argentina, Puerto Rico
Chongqing University Cancer Hospital
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Lymphoma

China
Charles University, Czech Republic

Active, not recruiting

The Reliability of the Nine Hole Peg Test in Patients With Multiple Sclerosis

Motor Activity

Czechia
University of Washington
National Cancer Institute (NCI)

Completed

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

Bladder Carcinoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors

Metastatic Gastrointestinal Carcinoid Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Regional Gastrointestinal Carcinoid Tumor

United States
Shandong University

Unknown

Efficacy of Tailored Bowel Preparation Strategy: A Randomized Controlled Study

Colonoscopy | Bowel Preparation

China
Polaris Group

Completed

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC)

Mesothelioma

United States, United Kingdom, Taiwan, Australia, Italy
Region Skane

Terminated

EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract

Gastrointestinal Neoplasms

Sweden
University Hospital, Ghent

Completed

EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer

Lung Cancer

Belgium
Bristol-Myers Squibb

Completed

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy (STRUCTURE)

Hepatitis C

France, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Taiwan, United Kingdom, United States, Spain, Israel, Argentina, Poland
Bristol-Myers Squibb

Completed

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 (PRINCIPAL)

Hepatitis C Virus (HCV)

Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
Hospices Civils de Lyon

Completed

Brain and Mindfulness (MEDITATION)

Healthy

France
Aeglea Biotherapeutics

Terminated

A Study of Safety of Weekly Subcutaneous Pegzilarginase in Subjects With Arginase 1 Deficiency

Arginase I Deficiency | Hyperargininemia

Canada
Aeglea Biotherapeutics

Completed

A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency (AEB1102)

Arginase I Deficiency | Hyperargininemia

United States, Canada, United Kingdom, Portugal
Peking University

Unknown

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma

China
Hoffmann-La Roche

Completed

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

Hepatitis C, Chronic

Brazil
Hoffmann-La Roche

Completed

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Hepatitis C, Chronic

Australia, France, Italy, Spain, United States, Canada, Germany, Puerto Rico, New Zealand
University of Nebraska

Terminated

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Chronic Hepatitis C | Relapse | Genotype 1

United States
Hoffmann-La Roche

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Hepatitis C, Chronic

United States, Puerto Rico
Bristol-Myers Squibb

Completed

Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials

Hepatitis C Virus Infection

Australia, France, Germany, Korea, Republic of, Sweden, Taiwan, United Kingdom, United States, Canada, Mexico, Austria, Italy, Spain, Denmark, Argentina, Poland, Ireland, Greece, New Zealand
Hoffmann-La Roche

Completed

A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Hepatitis B, Chronic

Estonia, Lithuania, Latvia
Mauna Kea Technologies

Unknown

Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas (CONTACT)

Pancreatic Neoplasms | Pancreatic Cancer | Lymphadenopathy | Pancreatic Cyst | Pancreatic Islet Cell Tumors | Pancreatic Adenoma | Lymph Node

France
Catholic University of the Sacred Heart

Completed

Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy (LowVolumePEG)

Colonic Polyps | Inflammatory Bowel Disease | Cancer Colon

Italy
GlaxoSmithKline

Completed

An Evaluation of Two Novel Nasal Strip Prototypes on Nasal Patency

Healthy Volunteer

United Kingdom
University of Colorado, Denver
Kansas City Veteran Affairs Medical Center

Completed

On-site Cytopathology EUS-FNA

Pancreatic Neoplasms | Pancreatic Cancer

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Shigella

United States

3

Subscribe